Owner
KM Intel LLC
Kirsten Messmer, PhD, RAC is the owner of KM Intel LLC which supports companies with actionable intelligence to inform their policy and regulatory strategy. She was previously a Senior Research Analyst and contributed to the research and development of content for AgencyIQ on regulatory issues affecting pharmaceutical and biopharmaceutical companies in the United States and the European Union.
Prior to joining Agency IQ, Kirsten was a Principal Regulatory Affairs Specialist at PPD providing global regulatory intelligence to support efficient, compliant and successful clinical research and drug development for biopharmaceuticals and advanced therapies. Before starting at PPD, Kirsten worked at Theradigm to develop stem cell therapies for neurodegenerative diseases before joining ERA Consulting. She held post-doctoral fellowships in London and Baltimore.
Kirsten received her PhD in Neuroscience from the University of Sheffield (Sheffield, UK) and a Biology Diploma from the Eberhard-Karls University (Tübingen, Germany). Kirsten also holds a Regulatory Affairs Certification (RAC) in US regulation.
Global Tools to Expedite Advanced Therapy Product Development
Wednesday, September 18, 2024
4:30 PM – 5:30 PM PDT
The European Pharmaceutical Legislation Revision – Status Update and Ongoing Challenges
Thursday, September 19, 2024
9:15 AM – 10:30 AM PDT